Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ropivacaine + morphine + epinephrine + ketorolac
- Development stage
- Unknown
- Lead developer
- QuVa Pharma
- Modality
- Small Molecules
- Administration
- Intraarticular, Periarticular
01
Overview
A multimodal analgesic combination used for periarticular and intraarticular pain management, particularly following orthopedic surgeries. This combination provides synergistic pain relief through multiple mechanisms: - Ropivacaine: A local anesthetic that inhibits afferent pain signals - Morphine: An opioid that provides analgesia through central and peripheral opioid receptors - Epinephrine: A vasoconstrictor that prolongs the local effect of the other drugs - Ketorolac: A non-steroidal anti-inflammatory drug that decreases the release of inflammatory mediators The combination is typically administered via intraarticular or periarticular injection during surgery, with some protocols including additional postoperative injections through catheters.
- Other names
- periarticular multimodal drug injectionintraarticular regional analgesiahigh-volume local infiltration analgesia
02
Targets
AR (Adrenergic receptors)NaV (Voltage-gated sodium channels)MOR (Mu opioid receptor)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)KCNA5 (Ultra-rapid delayed rectifier potassium channel)
Beyond the preview
Go deeper on ropivacaine + morphine + epinephrine + ketorolac.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ropivacaine + morphine + epinephrine + ketorolac.